GSA Capital Partners LLP Has $1.70 Million Holdings in Alignment Healthcare, Inc. $ALHC

GSA Capital Partners LLP lifted its holdings in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 162.7% during the fourth quarter, Holdings Channel.com reports. The firm owned 86,227 shares of the company’s stock after acquiring an additional 53,402 shares during the quarter. GSA Capital Partners LLP’s holdings in Alignment Healthcare were worth $1,703,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Handelsbanken Fonder AB raised its stake in Alignment Healthcare by 26.1% during the fourth quarter. Handelsbanken Fonder AB now owns 30,000 shares of the company’s stock worth $592,000 after buying an additional 6,200 shares during the last quarter. ProShare Advisors LLC raised its stake in Alignment Healthcare by 24.1% during the fourth quarter. ProShare Advisors LLC now owns 31,013 shares of the company’s stock worth $613,000 after buying an additional 6,015 shares during the last quarter. Northwestern Mutual Wealth Management Co. raised its stake in Alignment Healthcare by 7,684,933.3% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 691,653 shares of the company’s stock worth $13,660,000 after buying an additional 691,644 shares during the last quarter. Allworth Financial LP raised its stake in Alignment Healthcare by 8.9% during the fourth quarter. Allworth Financial LP now owns 6,917 shares of the company’s stock worth $137,000 after buying an additional 566 shares during the last quarter. Finally, Pier Capital LLC raised its stake in Alignment Healthcare by 140.5% during the fourth quarter. Pier Capital LLC now owns 546,674 shares of the company’s stock worth $10,797,000 after buying an additional 319,332 shares during the last quarter. Institutional investors and hedge funds own 86.19% of the company’s stock.

Insider Transactions at Alignment Healthcare

In other news, CEO John E. Kao sold 298,000 shares of the business’s stock in a transaction that occurred on Monday, May 11th. The shares were sold at an average price of $16.89, for a total value of $5,033,220.00. Following the sale, the chief executive officer owned 1,508,641 shares of the company’s stock, valued at $25,480,946.49. The trade was a 16.49% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 36,749 shares of the business’s stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $17.84, for a total transaction of $655,602.16. Following the completion of the sale, the president directly owned 1,058,813 shares in the company, valued at approximately $18,889,223.92. This trade represents a 3.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 1,569,859 shares of company stock worth $29,433,158. Corporate insiders own 5.20% of the company’s stock.

Alignment Healthcare Stock Up 0.5%

Alignment Healthcare stock opened at $16.36 on Wednesday. Alignment Healthcare, Inc. has a fifty-two week low of $11.63 and a fifty-two week high of $23.87. The stock has a market cap of $3.38 billion, a PE ratio of 181.78, a price-to-earnings-growth ratio of 2.28 and a beta of 1.26. The firm’s 50-day simple moving average is $18.93 and its 200 day simple moving average is $19.44. The company has a debt-to-equity ratio of 1.56, a quick ratio of 1.58 and a current ratio of 1.58.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.22 billion. During the same period in the previous year, the company earned ($0.05) earnings per share. The firm’s revenue for the quarter was up 33.3% compared to the same quarter last year. Research analysts predict that Alignment Healthcare, Inc. will post 0.19 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on ALHC. UBS Group lifted their target price on shares of Alignment Healthcare from $21.00 to $22.00 and gave the stock a “neutral” rating in a research note on Friday, May 1st. KeyCorp reaffirmed an “overweight” rating and issued a $28.00 price target on shares of Alignment Healthcare in a research note on Thursday, January 22nd. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, April 28th. Robert W. Baird set a $28.00 price target on shares of Alignment Healthcare in a research note on Friday, January 30th. Finally, Barclays boosted their target price on shares of Alignment Healthcare from $18.00 to $19.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Two research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $24.60.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.